POSA166 Cost-Effectiveness of Using Dapagliflozin in the Treatment of Heart Failure with Reduced Ejection Fraction: A Pharmacoeconomic Model Analysis
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.307
https://www.valueinhealthjournal.com/article/S1098-3015(21)02102-1/fulltext
Section Title :
Section Order :
11082
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02102-1&doi=10.1016/j.jval.2021.11.307